ValuEngine upgraded shares of Cabot (NYSE:CBT) from a strong sell rating to a sell rating in a report issued on Friday.

Several other analysts have also recently commented on CBT. TheStreet upgraded Cabot from a c+ rating to a b+ rating in a report on Tuesday, August 7th. Loop Capital set a $82.00 price target on Cabot and gave the company a buy rating in a report on Tuesday, November 6th. Northcoast Research set a $75.00 price target on Cabot and gave the company a buy rating in a report on Wednesday, November 7th. Zacks Investment Research cut Cabot from a buy rating to a sell rating in a report on Tuesday, October 16th. Finally, Barclays assumed coverage on Cabot in a report on Monday, October 8th. They issued an overweight rating and a $76.00 price target for the company. Two analysts have rated the stock with a sell rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus target price of $75.00.

CBT opened at $48.00 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.46 and a quick ratio of 0.92. The stock has a market capitalization of $3.04 billion, a price-to-earnings ratio of 11.91, a price-to-earnings-growth ratio of 1.02 and a beta of 1.50. Cabot has a 12 month low of $46.63 and a 12 month high of $68.63.

Cabot (NYSE:CBT) last posted its quarterly earnings results on Monday, November 5th. The specialty chemicals company reported $1.00 EPS for the quarter, missing the consensus estimate of $1.09 by ($0.09). The business had revenue of $850.00 million during the quarter, compared to analysts’ expectations of $856.76 million. Cabot had a negative net margin of 3.49% and a positive return on equity of 18.82%. The firm’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.91 EPS. As a group, sell-side analysts forecast that Cabot will post 4.59 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 14th. Stockholders of record on Friday, November 30th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.75%. The ex-dividend date of this dividend is Thursday, November 29th. Cabot’s payout ratio is currently 32.75%.

In other news, Director Patrick M. Prevost sold 40,519 shares of the business’s stock in a transaction dated Wednesday, August 22nd. The stock was sold at an average price of $65.65, for a total transaction of $2,660,072.35. Following the completion of the sale, the director now owns 216,894 shares in the company, valued at approximately $14,239,091.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.20% of the stock is currently owned by insiders.

Several large investors have recently modified their holdings of the company. TIAA CREF Investment Management LLC grew its holdings in shares of Cabot by 7.4% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 189,003 shares of the specialty chemicals company’s stock worth $11,854,000 after purchasing an additional 12,959 shares during the period. Teachers Advisors LLC grew its holdings in shares of Cabot by 7.4% during the 3rd quarter. Teachers Advisors LLC now owns 205,941 shares of the specialty chemicals company’s stock worth $12,917,000 after purchasing an additional 14,111 shares during the period. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its holdings in shares of Cabot by 12.7% during the 3rd quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 25,761 shares of the specialty chemicals company’s stock worth $1,616,000 after purchasing an additional 2,900 shares during the period. Man Group plc grew its holdings in shares of Cabot by 206.3% during the 3rd quarter. Man Group plc now owns 87,888 shares of the specialty chemicals company’s stock worth $5,513,000 after purchasing an additional 59,199 shares during the period. Finally, Vident Investment Advisory LLC grew its holdings in shares of Cabot by 19.0% during the 3rd quarter. Vident Investment Advisory LLC now owns 16,896 shares of the specialty chemicals company’s stock worth $1,060,000 after purchasing an additional 2,699 shares during the period. Institutional investors and hedge funds own 85.40% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods.

Further Reading: How to calculate the annual rate of depreciation

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.